The subject of the order is the successive supply of biological medicines for Dolnośląski Centrum Rehabilitacji Sp. z o. o. in Kamienna Góra.

A detailed assortment list of ordered medicines and their estimated quantities are set out in Part II of the ToR.

Medicines must have a marketing authorization in accordance with the Pharmaceutical Law of September 6, 2001 (i.e. the territory of the Republic of Poland. "

Rituximab violet. 500 mg / 50 ml, 1 vial. - 11 pcs.

Golimumab 50 mg / 0.5 ml solution to shake - 1 shock - 155 pcs.

Sekukinumab 150 mg / ml, 2 amps - shot - 99 pcs.

Tofacitinib 5 mg, 56 tablets - 50 op.

Tocilizumab 200 mg / 10 ml vial. - 74 pcs.

Tocilizumab 400 mg / 20 ml vial. - 149 items

Tocilizumab 80 mg / 4 ml vial. - 372 pcs.

Tocilizumab 162 mg / 0.9 ml, solution to shake x 4 amps - shot - 112 op.

Adalimumab 40 mg x 2 amp - syringe - 217 op.

Infliximab 100 mg vial. - 155 pcs.

Etanercept 50 mg x 4 amp - shock - 186 op.

Certolizumab 200 mg / ml x 2 amp - shot - 217 op.